“Those who know me from my role as Chairman of PolyNovo (ASX: PNV), know how excited I am to lead a company dedicated to saving lives and improving patient outcomes. We all have family and friends impacted by cancer and debilitating neurodegenerative diseases such as Alzheimer’s and Parkinson’s. Even more relevant, we all have mothers, daughters and sisters, so the work INOVIQ is doing on breast and ovarian cancer detection is of great interest.
While not immediately evident, INOVIQ’s Platform technologies like EXO-NET, underpin the Company’s growing pipeline of cancer diagnostics and therapeutics. EXO-NET ultimately helps researchers build new and better products to detect and treat disease earlier, leading to better patient outcomes.
For more information, download the attached PDF.
Download this document
